Ciliary neurotrophic factor receptor subunit alpha (CNTFR)

Ciliary neurotrophic factor receptor subunit alpha (CNTFR) is a glycosylphosphatidylinositol (GPI)-anchored membrane protein that functions as the specific ligand-binding component of the tripartite CNTF receptor complex. Unlike most cytokine receptors, it lacks a traditional transmembrane domain and relies on its association with signal-transducing subunits gp130 and leukemia inhibitory factor receptor (LIFR) to initiate downstream cascades such as the JAK/STAT and MAPK/ERK pathways. CNTFR is predominantly expressed in the nervous system and skeletal muscle, where it is critical for the survival and maintenance of motor neurons and the regulation of metabolic processes like appetite. Its role in disease is significant; deficiencies are linked to perinatal lethality and severe motor neuron deficits, while its activation is being explored for treating neurodegenerative diseases, retinal degeneration, and obesity. Therapeutic efforts have utilized recombinant CNTF variants and cell-based delivery systems to target this receptor, although clinical success has been hampered by systemic side effects and the development of neutralizing antibodies. Understanding CNTFR's specific interaction with its ligands remains a key area for developing neuroprotective and metabolic therapies.

Other names

Ciliary neurotrophic factor receptor alphaCNTFR-alphaCNTF receptor subunit alphaCNTFR subunit alpha

Binding of CNTF or its agonists to CNTFR-alpha triggers the recruitment and heterodimerization of gp130 and LIFR, leading to the activation of the JAK/STAT3 and MAPK/ERK signaling pathways.